Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.

Authors

Kris M Mahadeo
Sajad J Khazal
Hisham Abdel-Azim
Julie C Fitzgerald
Agne Taraseviciute
Catherine M Bollard, George Washington University
Priti Tewari
Christine Duncan
Chani Traube
David McCall
Marie E Steiner
Ira M Cheifetz
Leslie E Lehmann
Rodrigo Mejia
John M Slopis
Rajinder Bajwa
Partow Kebriaei
Paul L Martin
Jerelyn Moffet
Jennifer McArthur
Demetrios Petropoulos
Joan O'Hanlon Curry
Sarah Featherston
Jessica Foglesong
Basirat Shoberu
Alison Gulbis
Maria E Mireles
Lisa Hafemeister
Cathy Nguyen
Neena Kapoor
Katayoun Rezvani
Sattva S Neelapu
Elizabeth J Shpall

Document Type

Journal Article

Publication Date

8-6-2018

Journal

Nat Rev Clin Oncol

DOI

10.1038/s41571-018-0075-2

Comments

epub ahead of print

APA Citation

Mahadeo, K., Khazal, S., Abdel-Azim, H., Fitzgerald, J., Taraseviciute, A., Bollard, C., Tewari, P., Duncan, C., Traube, C., McCall, D., Steiner, M., Cheifetz, I., Lehmann, L., Mejia, R., Slopis, J., Bajwa, R., Kebriaei, P., Martin, P., Moffet, J., McArthur, J., Petropoulos, D., O'Hanlon Curry, J., Featherston, S., Foglesong, J., Shoberu, B., Gulbis, A., Mireles, M., Hafemeister, L., Nguyen, C., Kapoor, N., Rezvani, K., Neelapu, S., & Shpall, E. (2018). Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.. Nat Rev Clin Oncol, (). http://dx.doi.org/10.1038/s41571-018-0075-2

Peer Reviewed

1